These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22492781)

  • 1. Synthetic cannabinoid ajulemic acid exerts potent antifibrotic effects in experimental models of systemic sclerosis.
    Gonzalez EG; Selvi E; Balistreri E; Akhmetshina A; Palumbo K; Lorenzini S; Lazzerini PE; Montilli C; Capecchi PL; Lucattelli M; Baldi C; Gianchecchi E; Galeazzi M; Pasini FL; Distler JH
    Ann Rheum Dis; 2012 Sep; 71(9):1545-51. PubMed ID: 22492781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ajulemic acid exerts potent anti-fibrotic effect during the fibrogenic phase of bleomycin lung.
    Lucattelli M; Fineschi S; Selvi E; Garcia Gonzalez E; Bartalesi B; De Cunto G; Lorenzini S; Galeazzi M; Lungarella G
    Respir Res; 2016 May; 17(1):49. PubMed ID: 27153807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A synthetic PPAR-γ agonist triterpenoid ameliorates experimental fibrosis: PPAR-γ-independent suppression of fibrotic responses.
    Wei J; Zhu H; Komura K; Lord G; Tomcik M; Wang W; Doniparthi S; Tamaki Z; Hinchcliff M; Distler JH; Varga J
    Ann Rheum Dis; 2014 Feb; 73(2):446-54. PubMed ID: 23515440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid derivatives acting as dual PPARγ/CB2 agonists as therapeutic agents for systemic sclerosis.
    García-Martín A; Garrido-Rodríguez M; Navarrete C; Caprioglio D; Palomares B; DeMesa J; Rollland A; Appendino G; Muñoz E
    Biochem Pharmacol; 2019 May; 163():321-334. PubMed ID: 30825431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis.
    Avouac J; Palumbo K; Tomcik M; Zerr P; Dees C; Horn A; Maurer B; Akhmetshina A; Beyer C; Sadowski A; Schneider H; Shiozawa S; Distler O; Schett G; Allanore Y; Distler JH
    Arthritis Rheum; 2012 May; 64(5):1642-52. PubMed ID: 22139817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cannabinoid WIN55, 212-2 abrogates dermal fibrosis in scleroderma bleomycin model.
    Balistreri E; Garcia-Gonzalez E; Selvi E; Akhmetshina A; Palumbo K; Lorenzini S; Maggio R; Lucattelli M; Galeazzi M; Distler JW
    Ann Rheum Dis; 2011 Apr; 70(4):695-9. PubMed ID: 21177293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways.
    del Río C; Navarrete C; Collado JA; Bellido ML; Gómez-Cañas M; Pazos MR; Fernández-Ruiz J; Pollastro F; Appendino G; Calzado MA; Cantarero I; Muñoz E
    Sci Rep; 2016 Feb; 6():21703. PubMed ID: 26887982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tropisetron suppresses collagen synthesis in skin fibroblasts via α7 nicotinic acetylcholine receptor and attenuates fibrosis in a scleroderma mouse model.
    Stegemann A; Sindrilaru A; Eckes B; del Rey A; Heinick A; Schulte JS; Müller FU; Grando SA; Fiebich BL; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2013 Mar; 65(3):792-804. PubMed ID: 23440693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gamma.
    Wu M; Melichian DS; Chang E; Warner-Blankenship M; Ghosh AK; Varga J
    Am J Pathol; 2009 Feb; 174(2):519-33. PubMed ID: 19147827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and binding of peroxisome proliferator-activated receptor gamma by synthetic cannabinoid ajulemic acid.
    Liu J; Li H; Burstein SH; Zurier RB; Chen JD
    Mol Pharmacol; 2003 May; 63(5):983-92. PubMed ID: 12695526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of peroxisome proliferator-activated receptor gamma in mouse fibroblasts results in increased susceptibility to bleomycin-induced skin fibrosis.
    Kapoor M; McCann M; Liu S; Huh K; Denton CP; Abraham DJ; Leask A
    Arthritis Rheum; 2009 Sep; 60(9):2822-9. PubMed ID: 19714649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nintedanib inhibits fibroblast activation and ameliorates fibrosis in preclinical models of systemic sclerosis.
    Huang J; Beyer C; Palumbo-Zerr K; Zhang Y; Ramming A; Distler A; Gelse K; Distler O; Schett G; Wollin L; Distler JH
    Ann Rheum Dis; 2016 May; 75(5):883-90. PubMed ID: 25858641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of fibroblast metalloproteinases by ajulemic acid, a nonpsychoactive cannabinoid acid.
    Johnson DR; Stebulis JA; Rossetti RG; Burstein SH; Zurier RB
    J Cell Biochem; 2007 Jan; 100(1):184-90. PubMed ID: 16927387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of casein kinase II reduces TGFβ induced fibroblast activation and ameliorates experimental fibrosis.
    Zhang Y; Dees C; Beyer C; Lin NY; Distler A; Zerr P; Palumbo K; Susok L; Kreuter A; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2015 May; 74(5):936-43. PubMed ID: 24431397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PGC-1α regulates autophagy to promote fibroblast activation and tissue fibrosis.
    Zhang Y; Shen L; Zhu H; Dreissigacker K; Distler D; Zhou X; Györfi AH; Bergmann C; Meng X; Dees C; Trinh-Minh T; Ludolph I; Horch R; Ramming A; Schett G; Distler JHW
    Ann Rheum Dis; 2020 Sep; 79(9):1227-1233. PubMed ID: 32482644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis.
    Distler JH; Jüngel A; Huber LC; Schulze-Horsel U; Zwerina J; Gay RE; Michel BA; Hauser T; Schett G; Gay S; Distler O
    Arthritis Rheum; 2007 Jan; 56(1):311-22. PubMed ID: 17195235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. alpha-melanocyte-stimulating hormone suppresses bleomycin-induced collagen synthesis and reduces tissue fibrosis in a mouse model of scleroderma: melanocortin peptides as a novel treatment strategy for scleroderma?
    Kokot A; Sindrilaru A; Schiller M; Sunderkötter C; Kerkhoff C; Eckes B; Scharffetter-Kochanek K; Luger TA; Böhm M
    Arthritis Rheum; 2009 Feb; 60(2):592-603. PubMed ID: 19180474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The adipokine adiponectin has potent anti-fibrotic effects mediated via adenosine monophosphate-activated protein kinase: novel target for fibrosis therapy.
    Fang F; Liu L; Yang Y; Tamaki Z; Wei J; Marangoni RG; Bhattacharyya S; Summer RS; Ye B; Varga J
    Arthritis Res Ther; 2012 Oct; 14(5):R229. PubMed ID: 23092446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.